"10.1371_journal.pone.0126304","plos one","2015-05-05T00:00:00Z","Marcellene A Gates-Hollingsworth; Mark R Perry; Hongjing Chen; James Needham; Raymond L Houghton; Syamal Raychaudhuri; Mark A Hubbard; Thomas R Kozel","University of Nevada School of Medicine, Reno, Nevada, United States of America; Battelle Biomedical Research Center, Columbus, Ohio, United States of America; InBios International, Inc., Seattle, Washington, United States of America","Conceived and designed the experiments: MAG MRP HC JN RLH SR MAH TRK. Performed the experiments: MAG MRP HC JN MAH. Analyzed the data: MAG MAH TRK. Contributed reagents/materials/analysis tools: SR TRK. Wrote the paper: MAG TRK.","TRK is a coinventor of a licensed patent, which has generated no revenue, for compositions and methods of detection, prevention and treatment of anthrax and other infectious diseases. Patent details: Detecting bacterial infection by a polyglutamic acid- (PGA-) producing pathogen; administration of a capsular polypeptide of a pathogen of interest and a CD40 agonist; immunization US 7682796 B2. SR has ownership at InBios International, Inc. and HC, JN and RH are employees of InBios International, Inc. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","05","Marcellene A Gates-Hollingsworth","MAGH",8,TRUE,8,5,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
